Surveillance of Rabies Postexposure Prophylaxis in Greece: 4 Years Experience.


Journal

Vector borne and zoonotic diseases (Larchmont, N.Y.)
ISSN: 1557-7759
Titre abrégé: Vector Borne Zoonotic Dis
Pays: United States
ID NLM: 100965525

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 27 9 2018
medline: 16 8 2019
entrez: 26 9 2018
Statut: ppublish

Résumé

Rabies reemerged in Greek fauna during October 2012, 25 years after the last report in animals and 42 after the last human case. This study examined the administration of rabies postexposure prophylaxis (PEP) in humans over the period 2012-2016. A total of 1,454 individuals (62.6% males) received PEP. The vast majority (92.3%) of regimens was initiated in high risk for animal rabies areas (11.1 PEP per 100,000 residents per year). Among the exposed, 77.0% presented at a healthcare setting during the first 24 h after the incident; more severe injuries were associated with faster presentation (p < 0.05). A vaccine series was administered in 54.5% of exposed persons whereas 43.7% received both vaccine and immunoglobulin and 1.7% immunoglobulin only. Exposure to stray dogs represented 68.4% of all incidents. In exposures occurring in nonhigh risk for rabies areas, bat was the second most frequently involved animal (13.4% of incidents). All dogs and cats evaluated by a veterinarian and laboratory-confirmed rabid were initially deemed suspect for rabies during clinical examination or according to history. No human rabies cases were recorded during the period of the study. Surveillance of PEP represents a valuable tool for aiding assessment of present and future demands in prophylaxis biologicals, outlining the epidemiological profile of exposures and planning effective policies for the management of exposure incidents.

Identifiants

pubmed: 30251935
doi: 10.1089/vbz.2018.2344
doi:

Substances chimiques

Immunoglobulins 0
Rabies Vaccines 0

Types de publication

Journal Article

Langues

eng

Pagination

295-301

Auteurs

Georgios Dougas (G)

1 Hellenic Center for Disease Control and Prevention, Athens, Greece.

Vasileia Konte (V)

1 Hellenic Center for Disease Control and Prevention, Athens, Greece.

Konstantinos Mitrou (K)

1 Hellenic Center for Disease Control and Prevention, Athens, Greece.

Theano Georgakopoulou (T)

1 Hellenic Center for Disease Control and Prevention, Athens, Greece.

Agoritsa Baka (A)

1 Hellenic Center for Disease Control and Prevention, Athens, Greece.

Aikaterini Liona (A)

1 Hellenic Center for Disease Control and Prevention, Athens, Greece.

Dimitra Tatsiou (D)

1 Hellenic Center for Disease Control and Prevention, Athens, Greece.

Symeon Metallidis (S)

2 First Internal Medicine Department, Infectious Diseases Division, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Ioannis Istikoglou (I)

3 Infection Control Committee, "AHEPA" University Hospital, Thessaloniki, Greece.

Emmanuel Christodoulou (E)

4 Department of Internal Medicine, "G. Papanikolaou" General Hospital of Thessaloniki, Thessaloniki, Greece.

Michalis Stavrakakis (M)

4 Department of Internal Medicine, "G. Papanikolaou" General Hospital of Thessaloniki, Thessaloniki, Greece.

Chrysa Pargiana (C)

5 Infectious Diseases Hospital of Thessaloniki, Thessaloniki, Greece.

Foteini Tsalikoglou (F)

6 Ministry of Health, Athens, Greece.

Myrsini Tzani (M)

7 Department of Zoonoses, Animal Health Directorate, Directorate General of Veterinary Services, Ministry of Rural Development and Food, Athens, Greece.

Laskarina-Maria Korou (LM)

7 Department of Zoonoses, Animal Health Directorate, Directorate General of Veterinary Services, Ministry of Rural Development and Food, Athens, Greece.

Konstantia Tasioudi (K)

8 Virology Laboratory - National Reference Laboratory for Rabies in Animals, Department of Molecular Diagnostics, FMD, Virological, Rickettsial & Exotic Diseases, Athens Veterinary Center, Ministry of Rural Development and Food, Athens, Greece.

Maria Mavrouli (M)

9 Department of Microbiology, Medical School, University of Athens, Athens, Greece.

Georgia Vrioni (G)

9 Department of Microbiology, Medical School, University of Athens, Athens, Greece.

Sotirios Tsiodras (S)

10 National and Kapodistrian University of Athens Medical School, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH